Clinical Roundup Study shows that patients receiving CAR T-cell therapy have improved QOL six months post-treatment March 31, 2023Vol.49 No.13
Clinical Roundup MD Anderson study shows microbiome-based biomarkers may be used to predict to CAR T-cell therapy response March 31, 2023Vol.49 No.13
Clinical Roundup Study finds diverse differences in microbes in breast tumors from patients of different races March 31, 2023Vol.49 No.13
Clinical Roundup University of Cincinnati scientists develop radiation therapy delivery approach using engineered bacteria March 31, 2023Vol.49 No.13
Clinical Roundup Combination therapy shows potential as novel treatment for adenoid cystic carcinoma in phase II study March 31, 2023Vol.49 No.13
Clinical Roundup Phase I/Ib study shows novel immunotherapy delivery approach safe and beneficial for some melanoma patients with leptomeningeal disease March 31, 2023Vol.49 No.13
Drugs & Targets FDA grants full approval indication for Keytruda for certain patients with advanced MSI-H or dMMR solid tumors March 31, 2023Vol.49 No.13
Drugs & Targets Libtayo + chemo approved by EC for first-line treatment of advanced PD-L1-positive NSCLC March 31, 2023Vol.49 No.13
Drugs & Targets Predictive Oncology and Integra Therapeutics form collaboration focused on gene therapy March 31, 2023Vol.49 No.13
Drugs & Targets ArsenalBio’s lead product advances to clinical manufacturing following Thermo Fisher collaboration March 31, 2023Vol.49 No.13
